AR027945A1 - Uso de pramipexol en el tratamiento de transtornos de adiccion - Google Patents

Uso de pramipexol en el tratamiento de transtornos de adiccion

Info

Publication number
AR027945A1
AR027945A1 ARP010100754A ARP010100754A AR027945A1 AR 027945 A1 AR027945 A1 AR 027945A1 AR P010100754 A ARP010100754 A AR P010100754A AR P010100754 A ARP010100754 A AR P010100754A AR 027945 A1 AR027945 A1 AR 027945A1
Authority
AR
Argentina
Prior art keywords
pramipexol
treatment
addiction disorders
addiction
disorders
Prior art date
Application number
ARP010100754A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22676121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR027945(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AR027945A1 publication Critical patent/AR027945A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP010100754A 2000-02-23 2001-02-20 Uso de pramipexol en el tratamiento de transtornos de adiccion AR027945A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18424200P 2000-02-23 2000-02-23

Publications (1)

Publication Number Publication Date
AR027945A1 true AR027945A1 (es) 2003-04-16

Family

ID=22676121

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100754A AR027945A1 (es) 2000-02-23 2001-02-20 Uso de pramipexol en el tratamiento de transtornos de adiccion

Country Status (24)

Country Link
US (1) US6410579B2 (es)
EP (1) EP1257271B1 (es)
JP (1) JP2003523387A (es)
KR (1) KR20030016230A (es)
CN (1) CN1396826A (es)
AR (1) AR027945A1 (es)
AT (1) ATE326967T1 (es)
AU (1) AU781358B2 (es)
BR (1) BR0107983A (es)
CA (1) CA2397874A1 (es)
CO (1) CO5261586A1 (es)
DE (1) DE60119896T2 (es)
DK (1) DK1257271T3 (es)
ES (1) ES2263586T3 (es)
HK (1) HK1053058A1 (es)
MX (1) MXPA02008184A (es)
MY (1) MY127739A (es)
NZ (1) NZ520974A (es)
PE (1) PE20011074A1 (es)
PT (1) PT1257271E (es)
SI (1) SI1257271T1 (es)
TW (1) TWI250016B (es)
WO (1) WO2001062249A1 (es)
ZA (1) ZA200206119B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
EP2246053B1 (en) 2001-12-11 2013-09-18 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
AR040682A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
JP2007518754A (ja) * 2004-01-22 2007-07-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング モノアミン神経伝達物質再取込みインヒビターとドーパミンアゴニストを含む医薬組成物
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
EP2431027A1 (en) * 2004-08-13 2012-03-21 Boehringer Ingelheim International GmbH Extended release pellet formulation containing Pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
KR101406767B1 (ko) * 2004-08-13 2014-06-20 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을함유하는 연장 방출성 정제 제형, 이의 제조방법 및 이의용도
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
ATE537826T1 (de) 2006-05-16 2012-01-15 Knopp Neurosciences Inc Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
RU2454409C2 (ru) 2007-03-14 2012-06-27 Нопп Ньюросайенсиз, Инк. Синтез хирально очищенных замещенных бензотиазолдиаминов
EP2203448B1 (de) * 2007-09-21 2011-06-22 Sanofi-Aventis Phenothiazin-derivate mit doppelbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP2334185A4 (en) 2008-08-19 2011-09-21 Knopp Neurosciences Inc COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
DE102012108398B4 (de) 2012-09-10 2014-05-22 Schott Ag Kochfeld, Blende, Geräteeinhausung sowie Kamin- oder Ofensichtscheibe mit einem Hologramm und Verfahren zu dessen bzw. deren Herstellung, sowie Verwendung eines Substrats, auf welchem ein Phasenhologramm aufgebracht ist
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
SI3019167T1 (sl) 2013-07-12 2021-04-30 Knopp Biosciences Llc Zdravljenje povišanih ravni eozinofilcev in / ali bazofilcev
US9642840B2 (en) 2013-08-13 2017-05-09 Knopp Biosciences, Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
PL3033081T3 (pl) 2013-08-13 2021-08-30 Knopp Biosciences Llc Kompozycje i sposoby do leczenia przewlekłej pokrzywki

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572485D1 (en) 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit
DE3933738A1 (de) 1989-10-10 1991-04-11 Boehringer Ingelheim Kg Neue verwendung von 2-aminothiazol-derivaten (tsh)
DE3937271A1 (de) 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4241013A1 (de) 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
US5650420A (en) 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6001861A (en) 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
CA2384840A1 (en) * 1999-09-30 2001-04-05 The General Hospital Corporation Use of pramipexole as a treatment for cocaine craving

Also Published As

Publication number Publication date
BR0107983A (pt) 2003-01-28
ES2263586T3 (es) 2006-12-16
NZ520974A (en) 2004-04-30
EP1257271A1 (en) 2002-11-20
EP1257271B1 (en) 2006-05-24
JP2003523387A (ja) 2003-08-05
DE60119896D1 (de) 2006-06-29
TWI250016B (en) 2006-03-01
CN1396826A (zh) 2003-02-12
US6410579B2 (en) 2002-06-25
MY127739A (en) 2006-12-29
DE60119896T2 (de) 2006-11-09
CA2397874A1 (en) 2001-08-30
HK1053058A1 (zh) 2003-10-10
ZA200206119B (en) 2003-10-31
MXPA02008184A (es) 2002-11-29
ATE326967T1 (de) 2006-06-15
WO2001062249A1 (en) 2001-08-30
KR20030016230A (ko) 2003-02-26
PE20011074A1 (es) 2001-10-04
US20010041727A1 (en) 2001-11-15
AU781358B2 (en) 2005-05-19
CO5261586A1 (es) 2003-03-31
PT1257271E (pt) 2006-09-29
AU3445401A (en) 2001-09-03
DK1257271T3 (da) 2006-08-21
SI1257271T1 (sl) 2006-10-31

Similar Documents

Publication Publication Date Title
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
NO20032909D0 (no) Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav
DE60124662D1 (de) Karosseriestruktur
AR028622A1 (es) Derivados de tropano utiles en terapia
NO20013332D0 (no) Frac-plugg med kulehylse
ID30366A (id) Pakaian dalam sekali pakai
BR0113116B1 (pt) banheira.
DE29906372U1 (de) Badezeug mit Massagekugeln
AR028098A1 (es) Bebida estable en el ambiente
NO20032122L (no) Forbedret behandling
NO20024806D0 (no) Apomorfinderivater samt anvendelse derav
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
DK1345598T3 (da) Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser
DE60135797D1 (de) Kunstleder
DE60009451D1 (de) Massagegerät
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
ID29706A (id) Artikel kesehatan sekali pakai
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
AR028458A1 (es) Un estuche de combinacion usado en el tratamiento del paludismo
ITBO20030237A1 (it) Dispositivo per l'idromassaggio localizzato.
DE50106854D1 (de) Thermobehälter
FR2806620B1 (fr) Matelas immobilisateur antiretraction
NO20001292D0 (no) Erotisk artikkel/stimuleringsapparat
NO20034462D0 (no) Beskyttelsesplagg for overkroppen for bruk i toaletter

Legal Events

Date Code Title Description
FB Suspension of granting procedure